Cancer Research UK Chooses Medidata Clinical Cloud
March 27th 2015Cancer Research UK, a UK-based charitable funder of cancer research, has selected Medidata’s Clinical Cloud® cloud-based technology for EDC and management (Medidata Rave®) for Cancer Research UK’s Center for Drug Development (CDD)-based clinical trials at institutes, universities and hospitals across the UK.
ClinRegs Navigates Country-Specific Trial Regulatory Info
March 25th 2015The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), has launched ClinRegs, a public website designed to help clinical researchers navigate country-specific regulatory information as they plan and implement clinical trials.
Biomedical Systems Announces Affiliation With the ePRO Consortium
March 24th 2015Biomedical Systems, a premier global provider of centralized diagnostic services, announced its affiliation with the Electronic Patient-Reported Outcome (ePRO) Consortium, a program run by the Critical Path Institute (C-Path).
De-identifying Clinical Trials Data
March 20th 2015Whether we are referring to CSRs or to IPD, the personal information of trial participants needs to be de-identified prior to release. This article will describe the available methods for de-identifying clinical trial data, and the relative strengths and weaknesses of each.
EMA Marks 20th Anniversary with Congress & Book
March 19th 2015To celebrate 20 years since its opening, the European Medicines Agency (EMA) organized a one-day meeting this week. Called “Science, Medicines, Health: Patients at the heart of future innovation”, the invitation-only event in London focused on the EMA’s future role
Sentiment Analysis: Understand Your Healthcare Customers
March 17th 2015Sentiment analysis can give health care organizations a competitive edge in understanding what customers think about their healthcare experience, to help reduce costs and improve care service and to lead to new clinical research and treatments. In addition, it taps into a new channel of pharmacovigilance input information that can enable Marketing Authorization Holders to keep abreast of opinions on the safety of their products in real time.